← ANALYSTS · TIPRANKS
Tessa Romero · J.P. Morgan
Hits
57%
80 of 140 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+21.7%
Over a year after the rating, TipRanks’ measure
Our companies rated now
22
Buy / hold / sell: 14 / 5 / 3
Upside of the analyst’s targets
+131.6%
Average over 14 current targets, to the last price
The market’s answer to the ratings
+4.9%
Day-0 move against SPY in the rating’s direction, average over 12 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 15on TipRanks 16:35 | PRAXIWMPraxis Precision Medicines · $6.9B | Initiated | Buy | $700 | +189.5% | −1.5% | ↗ |
| Oct 14on TipRanks 08:25 | CYTKIWMCytokinetics · $8.9B | Reiterated | Buy | — | — | +4.0%next day +0.5% | ↗ |
| Oct 9on TipRanks 07:10 | DFTXIWMDefinium Therapeutics · $4.6B | Initiated | Buy | $84.00 | +161.7% | +7.4%next day −4.5% · 5 days −11.0% | ↗ |
| Sep 23on TipRanks 07:55 | WVEIWMWave Life Sciences · $629M | Downgrade | Hold | — | — | −8.5%next day +0.3% · 5 days −5.7% | ↗ |
| Sep 21on TipRanks 06:45 | SRRKIWMScholar Rock Holding · $4.9B | Assigned | Buy | $63.00 → $70.00+11.1% | +75.4% | +1.7%next day +6.3% · 5 days +3.0% | ↗ |
| Sep 19on TipRanks Sep 21 02:00 | XENEIWMXenon · $3.3B | Reiterated | Buy | $82.00 | +144.8% | −3.5%next day +0.3% · 5 days −4.8% | ↗ |
| Sep 13on TipRanks Sep 14 06:15 | BHVNIWMBiohaven Ltd. · $1.7B | Reiterated | Buy | — | — | −0.1%next day −1.9% · 5 days +10.6% | ↗ |
| Sep 8on TipRanks Sep 10 14:35 | DYNIWMDyne Therapeutics · $2.9B | Downgrade | Sell | $10.00 | −29.8% | −15.8%next day −5.0% · 5 days −10.7% | ↗ |
| Aug 20on TipRanks 08:55 | CYTKIWMCytokinetics · $8.9B | Reiterated | Buy | — | — | +0.1%next day −0.8% · 5 days −0.2% | ↗ |
| Aug 20on TipRanks 07:25 | EWTXIWMEdgewise Therapeutics · $4.1B | Assigned | Buy | $53.00 → $60.00+13.2% | +61.3% | −5.9%next day +1.6% · 5 days +1.0% | ↗ |
| Aug 19on TipRanks 09:30 | SEPNIWMSepterna, Inc. · $1.7B | Reiterated | Buy | $38.00 → $48.00+26.3% | +32.0% | +0.1%next day −6.3% · 5 days −8.0% | ↗ |
| Aug 17on TipRanks 12:00 | EYPTIWMEyePoint Pharmaceuticals · $271M | Downgrade | Hold | — | — | −66.5%next day +13.0% · 5 days +1.2% | ↗ |
| Aug 14on TipRanks 07:55 | OCSOculis Holding · $486M | Assigned | Buy | $23.00 → $20.00−13.0% | +174.3% | +1.1%next day +2.0% · 5 days +2.5% | ↗ |
| Aug 14on TipRanks 07:55 | UPBIWMUpstream Bio, Inc. · $185M | Reiterated | Hold | $8.00 → $9.00+12.5% | +226.1% | +2.5%next day +1.5% · 5 days 0.0% | ↗ |
| Jun 29on TipRanks Jun 30 06:35 | LRMRIWMLarimar Therapeutics · $207M | Reiterated | Buy | $9.00 | +353.4% | −14.2%next day −5.5% · 5 days +5.7% | ↗ |
| Jun 25on TipRanks 07:41 | LXEOIWMLexeo Therapeutics, Inc. · $227M | Reiterated | Buy | $12.00 → $9.00−25.0% | +240.9% | −4.0%next day +1.8% · 5 days −1.6% | ↗ |
| Jun 11on TipRanks 20:15 | NRIXIWMNurix Therapeutics · $2.7B | Reiterated | Buy | — | — | −0.7%next day −1.2% · 5 days +9.4% | ↗ |
| Jun 11on TipRanks Jun 10 19:25 | AGIOIWMAgios Pharma · $1.8B | Assigned | Hold | $36.00 → $31.00−13.9% | −1.0% | −2.3%next day +2.0% · 5 days +17.5% | ↗ |
| Jun 8on TipRanks Jun 9 07:10 | SPTXIWMSeaport Therapeutics, Inc. · $942M | Reiterated | Buy | $42.00 | +135.6% | −1.7%next day +9.3% · 5 days +5.5% | ↗ |
| May 26on TipRanks May 27 07:16 | NMRAIWMNeumora Therapeutics, Inc. · $80M | Reiterated | Sell | — | — | −1.2%next day +1.1% · 5 days −6.1% | ↗ |
| Apr 2on TipRanks Apr 5 14:15 | RCKTIWMRocket Pharmaceuticals · $259M | Reiterated | Sell | — | — | −2.0%next day −3.0% · 5 days −5.3% | ↗ |
| Mar 4on TipRanks 07:00 | ACADIWMACADIA Pharmaceuticals · $3.4B | Assigned | Buy | $34.00 | +77.8% | +3.3%next day −3.7% · 5 days −4.8% | ↗ |
| Nov 18on TipRanks 18:15 | PRMEIWMPrime Medicine, Inc. · $655M | Reiterated | Hold | — | — | +4.4%next day +0.7% · 5 days −2.8% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗